For a 78‑kg adult with type 1 diabetes on dexamethasone 2 mg, currently using insulin glargine (Lantus) 20 U, NPH (neutral protamine Hagedorn) insulin 100 U at 6 pm, insulin‑to‑carbohydrate ratio 1 U per 10 g carbohydrate, daytime insulin sensitivity factor 50 mg/dL per unit, and nighttime insulin sensitivity factor 15 mg/dL per unit, and given the reported glucose readings, what should the insulin‑to‑carbohydrate ratio, glargine dose, and NPH dose be adjusted to?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Insulin Dose Adjustments for Type 1 Diabetes on Dexamethasone with Tube Feeding

This patient requires immediate discontinuation of NPH insulin at 6 pm and a substantial increase in Lantus to approximately 40-50 units once daily, with aggressive upward titration of the insulin-to-carbohydrate ratio to 1:5-1:7 grams to counteract dexamethasone-induced insulin resistance. 1, 2, 3

Critical Context: Dexamethasone-Induced Hyperglycemia

This patient is experiencing severe hyperglycemia driven by dexamethasone 2 mg, which causes profound insulin resistance. The current regimen is fundamentally flawed:

  • NPH 100 units at 6 pm is inappropriate for type 1 diabetes 4, 1. Guidelines explicitly state that sliding scale or correctional insulin alone should never be used in type 1 diabetes, and the same principle applies to using NPH as the sole basal insulin in this context 4.

  • The Lantus dose of 20 units is grossly inadequate. Recent evidence on dexamethasone-induced hyperglycemia shows that current practice consistently underdoses basal insulin, leading to persistent hyperglycemia requiring excessive reactive bolus insulin 3.

Recommended Insulin Regimen

Basal Insulin (Lantus)

Increase Lantus to 40-50 units once daily (approximately 0.5-0.65 units/kg for this 78 kg patient):

  • The FDA label recommends that for type 1 diabetes, basal insulin should constitute approximately one-third of total daily insulin requirements 2
  • This patient's glucose readings (367→267→163→243→273 mg/dL) demonstrate persistent hyperglycemia despite 100 units of NPH, indicating total daily insulin needs of 100-150 units
  • Discontinue NPH entirely 1, 2. When converting from twice-daily NPH to once-daily Lantus, the recommended initial dose is 80% of total NPH, but this patient needs MORE insulin due to dexamethasone 2, 5
  • Lantus provides more stable 24-hour coverage with lower nocturnal hypoglycemia risk compared to NPH 6, 7, 8, 9

Insulin-to-Carbohydrate Ratio (ICR)

Tighten the ICR from 1:10 to 1:5-1:7 grams of carbohydrate:

  • The patient consumed 43g CHO at 8 am (requiring 4.3 units at 1:10 ratio) yet glucose rose from unknown baseline to 367 mg/dL by 1400
  • At 1800, glucose was 267 mg/dL; after eating 43g CHO at 1900, glucose was 163 at 2100 (likely from the 100 units NPH kicking in), then rebounded to 243 at 2 am and 273 at 7 am
  • Dexamethasone typically requires 2-3 times more prandial insulin 3. An ICR of 1:5-1:7 means 6-8.6 units per 43g CHO meal
  • For the tube feeding (226g CHO from 6 pm to 6 am = ~19g/hour), calculate bolus coverage: 226g ÷ 5-7 = 32-45 units divided across the feeding period

Correction Factor Adjustments

The current ISF values need revision:

  • Daytime ISF of 50 mg/dL per unit is too weak. Change to ISF 30-40 mg/dL per unit
  • Nighttime ISF of 15 mg/dL per unit is dangerously aggressive and risks hypoglycemia. Change to ISF 30-40 mg/dL per unit (same as daytime given the dexamethasone effect)

Implementation Algorithm

  1. Immediately stop NPH 100 units at 6 pm
  2. Start Lantus 45 units once daily (can give at any consistent time, but bedtime is traditional) 2
  3. Use ICR 1:6 for all carbohydrate intake (both meals and tube feeding)
  4. Apply ISF 1:35 for all correction doses (day and night)
  5. Monitor glucose every 4-6 hours initially, then adjust:
    • If fasting glucose >180 mg/dL for 2 consecutive days: increase Lantus by 10-20%
    • If fasting glucose 100-180 mg/dL: maintain dose
    • If fasting glucose <100 mg/dL or any hypoglycemia: reduce Lantus by 10-20%

Critical Pitfalls to Avoid

Do not continue NPH in type 1 diabetes during hospitalization 1. The guideline explicitly recommends continuation of scheduled insulin regimens in insulin-treated patients, but modification is required for nutritional status and severity of illness 1. This patient's regimen was already suboptimal.

Do not rely on reactive bolus insulin alone 3. The recent 2026 study on dexamethasone-induced hyperglycemia demonstrated that underdosing basal insulin and compensating with bolus insulin leads to persistent hyperglycemia in 76% of patients 3.

Adjust for tube feeding appropriately. The 226g CHO overnight requires either continuous insulin coverage or division of bolus doses every 4-6 hours during the feeding 1. Consider giving rapid-acting insulin every 4 hours during tube feeding: 226g ÷ 6 = ~38g per 4-hour period, requiring 6-7 units per dose at ICR 1:6.

Monitor closely for the first 48-72 hours 2. Dexamethasone effects peak 8-12 hours after administration and insulin requirements may fluctuate 3.

References

Guideline

management of diabetes and hyperglycaemia in the hospital.

The Lancet Diabetes and Endocrinology, 2021

Research

The Comparative Dosing and Glycemic Control of Intermediate and Long-Acting Insulins in Adult Patients With Type 1 and 2 Diabetes Mellitus.

The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians, 2022

Related Questions

For a 40‑year‑old man weighing 73 kg with type 1 diabetes who is on basal insulin glargine (Lantus) 14 U daily and fixed rapid‑acting insulin (insulin lispro, Novolog) doses of 18 U at breakfast, 14 U at lunch, and 10 U at dinner, and who received dexamethasone 6 mg 24 hours ago requiring an intravenous insulin drip, what should his basal glargine dose, insulin‑to‑carbohydrate ratio (ICR), and insulin sensitivity factor (ISF) be now that he is started on continuous subcutaneous insulin infusion (CSII)?
In a 40‑year‑old man weighing 73 kg with type 1 diabetes, creatinine 1.24 mg/dL, eGFR 75 mL/min, currently on insulin glargine (Lantus) 14 U daily and fixed bolus doses of insulin aspart (Novolog) 18 U at breakfast, 14 U at lunch, and 10 U at dinner, who received dexamethasone 6 mg 24 hours ago and is now started on continuous insulin infusion (CII), what should his insulin glargine (Lantus) dose, insulin‑sensitivity factor (ISF), and insulin‑to‑carbohydrate ratio (ICR) be?
For a 19‑year‑old patient with type 1 diabetes weighing 86.2 kg who is currently taking insulin glargine (Lantus) 12 U at 08:00 and 35 U at 20:00 and uses insulin‑to‑carbohydrate ratios of 1 U per 5 g carbs for breakfast and lunch and 1 U per 6 g carbs for dinner, what should the basal Lantus dose and insulin‑to‑carbohydrate ratio be adjusted to?
For a 27‑year‑old female on dexamethasone 20 mg daily who is currently taking 52 U of NPH insulin (Neutral Protamine Hagedorn) at 08:00 and using an insulin‑to‑carbohydrate ratio (ICR) of 3 g per unit (insulin sensitivity factor 15 mg/dL), with blood glucose readings of 213 mg/dL at 08:00, 269 mg/dL at 13:00, 96 mg/dL at 15:00, 278 mg/dL at 22:00, and 285 mg/dL at 01:00, what should the 08:00 NPH dose be, what should the ICR be, and what dose of NPH insulin should be added at 20:00?
For a 47-year-old male weighing 120 kg who is on dexamethasone 10 mg every 6 hours, what should the 10 am NPH (neutral protamine Hagedorn) insulin dose be, what should the 8 pm NPH dose be, and what should the insulin sensitivity factor (ISF) and insulin-to-carbohydrate ratio (ICR) be after changing dexamethasone to 10 mg every 8 hours?
For a patient presenting with pelvic pain and a history of endometriosis who was referred by a gynecologist, which nerve block is recommended?
What is the significance of blooming artifact on magnetic resonance imaging (MRI)?
What are alternative medications to naltrexone for treating opioid use disorder and alcohol use disorder?
Should the fallopian tubes be removed (salpingectomy) during a hysterectomy?
What other causes can explain a sensation of fullness or swelling in the pelvic region?
What antibiotic regimen is recommended for a patient with bacterial sinusitis who is allergic to ciprofloxacin, cefdinir, sulfonamides, penicillins, azithromycin (Zithromax), nitrofurantoin (Macrobid), and amoxicillin?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.